Literature DB >> 19768813

A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.

H Ishiguro1, O Carpio, Y Horiuchi, A Shu, S Higuchi, N Schanz, R Benno, T Arinami, E S Onaivi.   

Abstract

Marijuana use activates cannabinoid receptors (CB-Rs) producing several behavioral effects related to addiction, mood, and appetite. We investigated the association between CNR2 gene, which encodes cannabinoid CB2 receptor (CB2-R) and eating disorders in 204 subjects with eating disorders and 1876 healthy volunteers in Japanese population. The effect of treatment with CB2-R ligands on mouse food consumption was also determined. The CB2-R ligands used suppressed food intake in a time- and strain-dependent manner when food was available ad libitum and during the 12-h fast except, AM 630-the CB2-R antagonist that stimulated food consumption in food-deprived mice. There is an association between the R63Q polymorphism of the CNR2 gene and eating disorders (P = 0.04; Odds ratio 1.24, 95% CI, (1.01-1.53). These results suggest that cannabinoid CB2-R is involved in the endocannabinoid signaling mechanisms associated with the regulation of food intake and in eating disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19768813     DOI: 10.1002/syn.20714

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  24 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

Review 2.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

Review 3.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

4.  Psychiatric Disorders and Cannabinoid Receptors.

Authors:  Neal Joshi; Emmanuel S Onaivi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

6.  Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats.

Authors:  Hai-Ying Zhang; Guo-Hua Bi; Xia Li; Jie Li; Hong Qu; Shi-Jian Zhang; Chuan-Yun Li; Emmanuel S Onaivi; Eliot L Gardner; Zheng-Xiong Xi; Qing-Rong Liu
Journal:  Neuropsychopharmacology       Date:  2014-11-06       Impact factor: 7.853

7.  Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.

Authors:  Ewa Galaj; Guo-Hua Bi; Hong-Ju Yang; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-08-19       Impact factor: 5.250

Review 8.  What we know and do not know about the cannabinoid receptor 2 (CB2).

Authors:  Anna Maria Malfitano; Sreemanti Basu; Katarzyna Maresz; Maurizio Bifulco; Bonnie N Dittel
Journal:  Semin Immunol       Date:  2014-05-28       Impact factor: 11.130

9.  Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio).

Authors:  Zacharias Pandelides; Cammi Thornton; Anika S Faruque; Alyssa P Whitehead; Kristine L Willett; Nicole M Ashpole
Journal:  Geroscience       Date:  2020-03-27       Impact factor: 7.713

10.  Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear.

Authors:  Devon Ivy; Francesca Palese; Valentina Vozella; Yannick Fotio; Aylin Yalcin; Gina Ramirez; David Mears; Gary Wynn; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.